Kerr T - Search Results

1

A historical review of HIV prevention and care initiatives in British Columbia, Canada: 1996-2015.

Olding M, Enns B, Panagiotoglou D, Shoveller J, Harrigan PR, Barrios R, Kerr T, Montaner JSG, Nosyk B. Olding M, et al. Among authors: kerr t. J Int AIDS Soc. 2017 Sep 19;20(1):21941. doi: 10.7448/IAS.20.1.21941. J Int AIDS Soc. 2017. PMID: 28953322 Free PMC article. Review.

2

Unsafe injection practices in a cohort of injection drug users in Vancouver: could safer injecting rooms help?

Wood E, Tyndall MW, Spittal PM, Li K, Kerr T, Hogg RS, Montaner JS, O'Shaughnessy MV, Schechter MT. Wood E, et al. Among authors: kerr t. CMAJ. 2001 Aug 21;165(4):405-10. CMAJ. 2001. PMID: 11531048 Free PMC article.

3

Rationale for evaluating North America's first medically supervised safer-injecting facility.

Wood E, Kerr T, Montaner JS, Strathdee SA, Wodak A, Hankins CA, Schechter MT, Tyndall MW. Wood E, et al. Among authors: kerr t. Lancet Infect Dis. 2004 May;4(5):301-6. doi: 10.1016/S1473-3099(04)01006-0. Lancet Infect Dis. 2004. PMID: 15120347

4

Displacement of Canada's largest public illicit drug market in response to a police crackdown.

Wood E, Spittal PM, Small W, Kerr T, Li K, Hogg RS, Tyndall MW, Montaner JS, Schechter MT. Wood E, et al. Among authors: kerr t. CMAJ. 2004 May 11;170(10):1551-6. doi: 10.1503/cmaj.1031928. CMAJ. 2004. PMID: 15136548 Free PMC article.

5

Inability to access addiction treatment and risk of HIV infection among injection drug users.

Wood E, Spittal P, Li K, Kerr T, Miller CL, Hogg RS, Montaner JS, Schechter MT. Wood E, et al. Among authors: kerr t. J Acquir Immune Defic Syndr. 2004 Jun 1;36(2):750-4. doi: 10.1097/00126334-200406010-00013. J Acquir Immune Defic Syndr. 2004. PMID: 15167295

6

Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver.

Kerr T, Palepu A, Barness G, Walsh J, Hogg R, Montaner J, Tyndall M, Wood E. Kerr T, et al. Antivir Ther. 2004 Jun;9(3):407-14. Antivir Ther. 2004. PMID: 15259903

7

Staging for antiretroviral therapy among HIV-infected drug users.

Wood E, Hogg RS, Bonner S, Kerr T, Li K, Palepu A, Guillemi S, Schechter MT, Montaner JS. Wood E, et al. Among authors: kerr t. JAMA. 2004 Sep 8;292(10):1175-7. doi: 10.1001/jama.292.10.1175-b. JAMA. 2004. PMID: 15353528 No abstract available.

8

Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users.

Wood E, Kerr T, Small W, Li K, Marsh DC, Montaner JS, Tyndall MW. Wood E, et al. Among authors: kerr t. CMAJ. 2004 Sep 28;171(7):731-4. doi: 10.1503/cmaj.1040774. CMAJ. 2004. PMID: 15451834 Free PMC article.

9

Methodology for evaluating Insite: Canada's first medically supervised safer injection facility for injection drug users.

Wood E, Kerr T, Lloyd-Smith E, Buchner C, Marsh DC, Montaner JS, Tyndall MW. Wood E, et al. Among authors: kerr t. Harm Reduct J. 2004 Nov 9;1(1):9. doi: 10.1186/1477-7517-1-9. Harm Reduct J. 2004. PMID: 15535885 Free PMC article.

10

Baseline self-perceived risk of HIV infection independently predicts the rate of HIV seroconversion in a prospective cohort of injection drug users.

Wood E, Li K, Miller CL, Hogg RS, Montaner JS, Schechter MT, Kerr T. Wood E, et al. Among authors: kerr t. Int J Epidemiol. 2005 Feb;34(1):152-8. doi: 10.1093/ije/dyh357. Epub 2004 Nov 23. Int J Epidemiol. 2005. PMID: 15561747

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

987 results

Search Page

Filters